Crystal structure of a mirror-image L-RNA aptamer (Spiegelmer) in complex with the natural L-protein target CCL2
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
We report the crystal structure of a 40mer mirror-image RNA oligonucleotide completely built from nucleotides of the non-natural L-chirality in complex with the pro-inflammatory chemokine L-CLL2 (monocyte chemoattractant protein-1), a natural protein composed of regular L-amino acids. The L-oligonucleotide is an L-aptamer (a Spiegelmer) identified to bind L-CCL2 with high affinity, thereby neutralizing the chemokine’s activity. CCL2 plays a key role in attracting and positioning monocytes; its overexpression in several inflammatory diseases makes CCL2 an interesting pharmacological target. The PEGylated form of the L-aptamer, NOX-E36 (emapticap pegol), already showed promising efficacy in clinical Phase II studies conducted in diabetic nephropathy patients. The structure of the L-oligonucleotide·L-protein complex was solved and refined to 2.05 Å. It unveils the L-aptamer’s intramolecular contacts and permits a detailed analysis of its structure–function relationship. Furthermore, the analysis of the intermolecular drug–target interactions reveals insight into the selectivity of the L-aptamer for certain related chemokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Overview of the CCP 4 suite and current developments
Winn, M. D., Ballard, C. C., Cowtan, K. D., Dodson, E. J., Emsley, P., Evans, P. R., Keegan, R. M., Krissinel, E. B., Leslie, A. G. W., McCoy, A., et al. (2011) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910045749 · Cited by 12,353
Towards automated crystallographic structure refinement with phenix.refine
Afonine, P. V., Grosse-Kunstleve, R. W., Echols, N., Headd, J. J., Moriarty, N. W., Mustyakimov, M., Terwilliger, T. C., Urzhumtsev, A., Zwart, P. H., & Adams, P. D. (2012) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444912001308 · Cited by 5,511
Gerard, C., & Rollins, B. J. (2001) · Nature Immunology · doi:10.1038/84209 · Cited by 1,357
Baeck, C., Wehr, A., Karlmark, K. R., Heymann, F., Vucur, M., Gassler, N., Huss, S., Klussmann, S., Eulberg, D., Luedde, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300304 · Cited by 609
Geometry of metal–ligand interactions in proteins
Harding, M. M. (2001) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444900019168 · Cited by 348
Research works printed but not linked: 53
- Baggiolini, M., Dewald, B. & Moser, B. Human chemokines: an update. Annu. Rev. Immunol. 15, 675–705 (1997). · DOI · Paper page
- Allen, S. J., Crown, S. E. & Handel, T. M. Chemokine: receptor structure, interactions, and antagonism. Annu. Rev. Immunol. 25, 787–820 (2007). · DOI · Paper page
- Wang, X., Sharp, J. S., Handel, T. M. & Prestegard, J. H. Chemokine oligomerization in cell signaling and migration. Prog. Mol. Biol. Transl. Sci. 117, 531–578 (2013). · DOI
- Proudfoot, A. E. et al. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl Acad. Sci. USA 100, 1885–1890 (2003). · DOI · Paper page
- Dawson, J., Miltz, W., Mir, A. K. & Wiessner, C. Targeting monocyte chemoattractant protein-1 signalling in disease. Expert. Opin. Ther. Targets 7, 35–48 (2003). · DOI
- Yadav, A., Saini, V. & Arora, S. MCP-1: chemoattractant with a role beyond immunity: a review. Clin. Chim. Acta 411, 1570–1579 (2010). · DOI · Paper page
- Eulberg, D., Purschke, W., Anders, H.-J., Selve, N. & Klussmann, S. Spiegelmer NOX-E36 for renal diseases. in Therapeutic Oligonucleotides ed. Kurreck J. 200–225Royal Society of Chemistry (2008). · DOI
- Eulberg, D., Jarosch, F., Vonhoff, S. & Klussmann, S. Spiegelmers for therapeutic applications—use of chiral principles in evolutionary selection techniques. in The Aptamer Handbook ed. Klussmann S. 417–442Wiley-VCH, Weinheim (2006). · DOI
- Tuerk, C. & Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505–510 (1990). · DOI · Paper page
- Kulkarni, O. et al. Spiegelmer inhibition of CCL2/MCP-1 ameliorates lupus nephritis in MRL-(Fas)lpr mice. J. Am. Soc. Nephrol. 18, 2350–2358 (2007). · DOI · Paper page
- Ninichuk, V. et al. Late onset of Ccl2 blockade with the Spiegelmer mNOX-E36-3'PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice. Am. J. Pathol. 172, 628–637 (2008). · DOI
- Yatime, L. et al. Structural basis for the targeting of complement anaphylatoxin C5a using a mixed L-RNA/L-DNA aptamer. Nat. Commun. 6, 6481 (2015). · DOI · Paper page
- Sheng, J. & Huang, Z. Selenium derivatization of nucleic acids for phase and structure determination in nucleic acid X-ray crystallography. Int. J. Mol. Sci. 9, 258–271 (2008). · doi:10.3390/ijms9030258
- Hendrickson, W. A. & Teeter, M. M. Structure of the hydrophobic protein crambin determined directly from the anomalous scattering of sulphur. Nature 290, 107–113 (1981). · DOI · Paper page
- Lubkowski, J. et al. The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions. Nat. Struct. Biol. 4, 64–69 (1997). · DOI
- Handel, T. M. & Domaille, P. J. Heteronuclear (1H, 13C, 15N) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimer. Biochemistry 35, 6569–6584 (1996). · DOI · Paper page
- Zuker, M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31, 3406–3415 (2003). · DOI · Paper page
- Reuter, H., Kamaha, S. & Zerzouf, O. Hydrogen bonds in the crystal structure of strontium hydroxide octahydrate Sr(OH)2·8H2O. Z. Naturforsch. 62b, 215–219 (2007). · doi:10.1515/znb-2007-0212
- D'Angelo, P. & Persson, I. Structure of the hydrated and dimethyl sulfoxide solvated rubidium ions in solution. Inorg. Chem. 43, 3543–3549 (2004). · DOI
- Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486–501 (2010). · DOI · Paper page
- Zheng, H. et al. Validation of metal-binding sites in macromolecular structures with the CheckMyMetal web server. Nat. Protoc. 9, 156–170 (2014). · DOI · Paper page
- Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774–797 (2007). · DOI · Paper page
- Hemmerich, S. et al. Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2. Biochemistry 38, 13013–13025 (1999). · DOI
- Jarnagin, K. et al. Identification of surface residues of the monocyte chemotactic protein 1 that affect signaling through the receptor CCR2. Biochemistry 38, 16167–16177 (1999). · DOI
- Chakravarty, L., Rogers, L., Quach, T., Breckenridge, S. & Kolattukudy, P. E. Lysine 58 and histidine 66 at the C-terminal α-helix of monocyte chemoattractant protein-1 are essential for glycosaminoglycan binding. J. Biol. Chem. 273, 29641–29647 (1998). · DOI
- Lau, E. K. et al. Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: implications for structure and function in vivo. J. Biol. Chem. 279, 22294–22305 (2004). · DOI · Paper page
- Blaszczyk, J. et al. Complete crystal structure of monocyte chemotactic protein-2, a CC chemokine that interacts with multiple receptors. Biochemistry 39, 14075–14081 (2000). · DOI
- Crump, M. P., Rajarathnam, K., Kim, K. S., Clark-Lewis, I. & Sykes, B. D. Solution structure of eotaxin, a chemokine that selectively recruits eosinophils in allergic inflammation. J. Biol. Chem. 273, 22471–22479 (1998). · DOI
- Barinka, C., Prahl, A. & Lubkowski, J. Structure of human monocyte chemoattractant protein 4 (MCP-4/CCL13). Acta Crystallogr. D Biol. Crystallogr. 64, 273–278 (2008). · doi:10.1107/s0907444907066164
- Kim, K. S., Rajarathnam, K., Clark-Lewis, I. & Sykes, B. D. Structural characterization of a monomeric chemokine: monocyte chemoattractant protein-3. FEBS Lett. 395, 277–282 (1996). · DOI
- Landgraf, G. et al. Pharmacokinetics, pharmacodynamics, safety and tolerability of the CCL2 antagonist NOX-E36, a novel agent being investigated for treatment of diabetic nephropathy [Abstract]. J. Am. Soc. Nephrol. 23, 960A (2012).
- Padlan, C. S. et al. An RNA aptamer possessing a novel monovalent cation-mediated fold inhibits lysozyme catalysis by inhibiting the binding of long natural substrates. RNA 20, 447–461 (2014). · DOI
- Morozova, N., Allers, J., Myers, J. & Shamoo, Y. Protein-RNA interactions: exploring binding patterns with a three-dimensional superposition analysis of high resolution structures. Bioinformatics 22, 2746–2752 (2006). · DOI · Paper page
- Rooman, M., Lievin, J., Buisine, E. & Wintjens, R. Cation-pi/H-bond stair motifs at protein-DNA interfaces. J. Mol. Biol. 319, 67–76 (2002). · DOI
- Wintjens, R., Lievin, J., Rooman, M. & Buisine, E. Contribution of cation-pi interactions to the stability of protein-DNA complexes. J. Mol. Biol. 302, 395–410 (2000). · DOI · Paper page
- Keefe, A. D., Pai, S. & Ellington, A. Aptamers as therapeutics. Nat. Rev. Drug Discov. 9, 537–550 (2010). · DOI · Paper page
- Obmolova, G. et al. Structural basis for high selectivity of anti-CCL2 neutralizing antibody CNTO 888. Mol. Immunol. 51, 227–233 (2012). · DOI
- Reid, C. et al. Structure activity relationships of monocyte chemoattractant proteins in complex with a blocking antibody. Protein Eng. Des. Sel. 19, 317–324 (2006). · DOI
- Pienta, K. J. et al. Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer. Invest. New Drugs 31, 760–768 (2013). · DOI · Paper page
- Sandhu, S. K. et al. A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors. Cancer Chemother. Pharmacol. 71, 1041–1050 (2013). · DOI · Paper page
- Hoffmann, S., Hoos, J., Klussmann, S. & Vonhoff, S. RNA aptamers and spiegelmers: synthesis, purification, and post-synthetic PEG conjugation. Curr. Protoc. Nucleic Acid Chem. Chapter 4, Unit 4.46.1–30 (2011). · DOI · Paper page
- Kabsch, W. Integration, scaling, space-group assignment and post-refinement. Acta Crystallogr. D 66, 133–144 (2010). · DOI · Paper page
- Kabsch, W. XDS.. Acta Crystallogr. D 66, 125–132 (2010). · DOI · Paper page
- Grosse-Kunstleve, R. W. & Adams, P. D. Substructure search procedures for macromolecular structures. Acta Crystallog. D Biol. Crystallogr. 59, 1966–1973 (2003). · DOI · Paper page
- Terwilliger, T. C. et al. Decision-making in structure solution using Bayesian estimates of map quality: the PHENIX AutoSol wizard. Acta Crystallogr. D Biol. Crystallogr. 65, 582–601 (2009). · DOI · Paper page
- Murshudov, G. N., Vagin, A. A. & Dodson., E. J. Refinement of Macromolecular Structures by the Maximum-Likelihood method. Acta Cryst. D 53, 1285–1294 (1997). · DOI · Paper page
- Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D Biol. Crystallogr. 67, 355–367 (2011). · DOI · Paper page
- Zheng, H., Chruszcz, M., Lasota, P., Lebioda, L. & Minor, W. Data mining of metal ion environments present in protein structures. J. Inorg. Biochem. 102, 1765–1776 (2008). · DOI · Paper page
- Allen, F. H. The Cambridge Structural Database: a quarter of a million crystal structures and rising. Acta Crystallogr.B Struct. Sci. 58, 380–388 (2002). · DOI · Paper page
- Auffinger, P., Grover, N. & Westhof, E. Metal ion binding to RNA. Metal Ion Life Sci. 9, 1–35 (2011).
- Pettersen, E. F. et al. Chimera--a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004). · DOI · Paper page
- Laskowski, R. A. & Swindells, M. B. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model 51, 2778–2786 (2011). · DOI · Paper page
- Lu, X. J. & Olson, W. K. 3DNA: a versatile, integrated software system for the analysis, rebuilding and visualization of three-dimensional nucleic-acid structures. Nat. Protoc. 3, 1213–1227 (2008). · DOI · Paper page
Cited by
Aptamers as targeted therapeutics: current potential and challenges
Zhou, J., & Rossi, J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.199 · Cited by 2,221
Liver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Parola, M., & Pinzani, M. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.09.002 · Cited by 1,160
Röthlisberger, P., & Hollenstein, M. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.007 · Cited by 413
Aptamers in the Therapeutics and Diagnostics Pipelines
Kaur, H., Bruno, J. G., Kumar, A., & Sharma, T. K. (2018) · Theranostics · doi:10.7150/thno.25958 · Cited by 366
Metadata
- Authors
- Oberthür, D., Achenbach, J., Gabdulkhakov, A., Buchner, K., Maasch, C., Falke, S., Rehders, D., Klussmann, S., & Betzel, C.
- Venue
- Nature Communications
- Published
- 2015-04-22
- Volume
- 6
- Issue
- 1
- Pages
- 6923-6923
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2138136706
- Cited by
- 102
- References
- 5
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.